Early cerebral damage in patients with manifest vascular disease: The second MR for SMART (SMS) study: Rationale and design

被引：0
|
作者：
Appelman, A. P. A.
van der Graaf, Y.
Mali, W. P. T. h. M.
机构：
[1] Dept Radiol, Utrecht, Netherlands
[2] Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
来源：
EUROPEAN JOURNAL OF EPIDEMIOLOGY | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [1] Second Manifestations of ARTerial disease (SMART) study: Rationale and design
    Algra, A.
    van der Graaf, Y.
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2006, 21 : 20 - 21
  • [2] Second Manifestations of ARTerial disease (SMART) study: Rationale and design
    P.C.G. Simons
    A. Algra
    M.F. van de Laak
    D.E. Grobbee
    Y. van der Graaf
    European Journal of Epidemiology, 1999, 15 : 773 - 781
  • [3] Second Manifestations of ARTerial disease (SMART) study: Rationale and design
    Simons, PCG
    Algra, A
    van de Laak, MF
    Grobbee, DE
    van der Graaf, Y
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1999, 15 (09) : 773 - 781
  • [4] Extracellular vesicle protein levels are related to brain atrophy and cerebral white matter lesions in patients with manifest vascular disease: the SMART-MR study
    Kanhai, Danny A.
    de Kleijn, Dominique P. V.
    Kappelle, L. Jaap
    Uiterwaal, Cuno S. P. M.
    van der Graaf, Yolanda
    Pasterkamp, Gerard
    Geerlings, Mirjam I.
    Visseren, Frank L. J.
    BMJ OPEN, 2014, 4 (01):
  • [5] Relationship between recurrent miscarriage and early preterm delivery and recurrent events in patients with manifest vascular disease: The SMART study
    Heida, Karst Y.
    Koster, Maria P. H.
    Franx, Arie
    Veerbeek, Jan H. W.
    Westerink, Jan
    Bots, Michiel L.
    Spiering, Wilko
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (05) : 486 - 492
  • [6] Study Rationale and Design of ADVANCE: Action in and vascular disease - preterax and diamicron MR evaluation
    Chalmers, J
    Cooper, M
    Ferrannini, E
    Glasziou, P
    Grobbee, D
    Hamet, P
    Harrap, S
    Liu, L
    MacMahon, S
    Mancia, G
    Marre, M
    Matthews, D
    Mogensen, C
    Neal, B
    Pan, CY
    Poulter, N
    Rodgers, A
    Williams, B
    Woodward, M
    DIABETOLOGIA, 2001, 44 (09) : 1118 - 1120
  • [7] Blood Pressure Not Associated with Cerebral White Matter Lesions in Patients with Vascular Disease: The SMART-MR Study
    Vlek, Anne L.
    Visseren, Frank L.
    Kappelle, Jaap
    Witkamp, Theo D.
    Vincken, Koen L.
    Mali, Willem P.
    van der Graaf, Yolanda
    CIRCULATION, 2009, 119 (10) : E324 - E324
  • [8] Hypertensive target organ damage and longitudinal changes in brain structure and function in older patients with manifest cardiovascular disease: The SMART-MR study
    Muller, M.
    Van Der Veen, P. H.
    Visseren, F. L. J.
    Nathoe, H. M.
    Mali, W. P. T. M.
    Van Der Graaf, Y.
    Geerlings, M. I.
    EUROPEAN HEART JOURNAL, 2015, 36 : 894 - 894
  • [9] The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study
    Soedamah-Muthu, S. S.
    Visseren, F. L. J.
    Algra, A.
    van der Graaf, Y.
    DIABETIC MEDICINE, 2008, 25 (01) : 51 - 57
  • [10] Alcohol consumption and risk of recurrent cardiovascular events and mortality in patients with clinically manifest vascular disease and diabetes mellitus: The Second Manifestations of ARTerial (SMART) disease study
    Beulens, J. W. J.
    Algra, A.
    Soedamah-Muthu, S. S.
    Visseren, F. L. J.
    Grobbee, D. E.
    van der Graaf, Y.
    ATHEROSCLEROSIS, 2010, 212 (01) : 281 - 286
12345